United States Biotechnology & Medical Research

Adolor Corp (ADLR)

Track

Track

Ticker: ADLR Exchange: NMQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
CUBIST PHARMACEUTICALS INC Large shareholder
Transaction date
Purchase
Price
214.93
Quantity 69,647 +18.1%
Value US$4,970,543
CUBIST PHARMACEUTICALS INC Large shareholder
Transaction date
Purchase
Price
280.46
Quantity 64,704 -8.3%
Value US$2,284,185
CUBIST PHARMACEUTICALS INC Large shareholder
Transaction date
Purchase
Price
40.67
Quantity 9,609 -29.8%
Value US$3,239,081
CUBIST PHARMACEUTICALS INC Large shareholder
Transaction date
Purchase
Price
4.25
Quantity 1,180,983 +2.9%
Value US$5,019,178
CUBIST PHARMACEUTICALS INC Large shareholder
Transaction date
Purchase
Price
4.25
Quantity 4,306,129 +11.9%
Value US$18,301,048
MADDEN DAVID Non-Executive Director
Transaction date
Purchase
Price
4.66
Quantity 18,425 +1.7%
Value US$85,860
MADDEN DAVID Non-Executive Director
Transaction date
Purchase
Price
4.65
Quantity 61,650 +6.0%
Value US$286,672
NICKELSON DONALD E Non-Executive Director
Transaction date
Purchase
Price
4.62
Quantity 35,000 +11.4%
Value US$161,700
NICKELSON DONALD E Non-Executive Director
Transaction date
Purchase
Price
4.67
Quantity 100,000 +48.1%
Value US$467,000
NICKELSON DONALD E Non-Executive Director
Transaction date
Purchase
Price
4.73
Quantity 72,896 +53.9%
Value US$344,798
NICKELSON DONALD E Non-Executive Director
Transaction date
Purchase
Price
4.58
Quantity 2,643 +2.0%
Value US$12,105
NICKELSON DONALD E Non-Executive Director
Transaction date
Purchase
Price
4.59
Quantity 24,461 +22.6%
Value US$112,276
Webster Stephen W SVP, Finance & CFO Officer
Transaction date
Purchase
Price
1.88
Quantity 10,000 +7.8%
Value US$18,800
Limongelli John M SVP, General Counsel & Secr. Officer
Transaction date
Purchase
Price
1.80
Quantity 3,010 +1.6%
Value US$5,418
Limongelli John M SVP, General Counsel & Secr. Officer
Transaction date
Purchase
Price
1.90
Quantity 13,190 +7.6%
Value US$25,061
DOUGHERTY MICHAEL R President & CEO Executive Director
Transaction date
Purchase
Price
1.18
Quantity 30,000 +5.1%
Value US$35,400
Baker Biotech Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.18
Quantity 376 -0.5%
Value US$445
Baker Bros. Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.18
Quantity 14 -0.5%
Value US$17
14159 capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.18
Quantity 884 -0.5%
Value US$1,046
Baker / Tisch Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.18
Quantity 60 -0.5%
Value US$71
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.18
Quantity 31,666 -0.5%
Value US$37,461
Baker Biotech Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.19
Quantity 885 -1.1%
Value US$1,052
Baker Bros. Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.19
Quantity 33 -1.1%
Value US$39
14159 capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.19
Quantity 2,086 -1.1%
Value US$2,479
Baker / Tisch Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.19
Quantity 142 -1.1%
Value US$169
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.19
Quantity 74,670 -1.1%
Value US$88,738
Baker Biotech Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.30
Quantity 569 -0.7%
Value US$740
Baker Bros. Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.30
Quantity 21 -0.7%
Value US$27
14159 capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.30
Quantity 1,341 -0.7%
Value US$1,743
Baker / Tisch Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.30
Quantity 91 -0.7%
Value US$118
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.30
Quantity 47,978 -0.7%
Value US$62,371
Baker Biotech Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.28
Quantity 233 -0.3%
Value US$298
Baker Bros. Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.28
Quantity 9 -0.3%
Value US$11
14159 capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.28
Quantity 550 -0.3%
Value US$702
Baker / Tisch Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.28
Quantity 37 -0.3%
Value US$47
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
1.28
Quantity 19,671 -0.3%
Value US$25,120
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.58
Quantity 2,238 +0.0%
Value US$3,536
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.64
Quantity 405,401 +6.3%
Value US$664,736
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.58
Quantity 62 +0.0%
Value US$98
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.64
Quantity 11,190 +6.2%
Value US$18,348
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.56
Quantity 21,604 +0.3%
Value US$33,750
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.56
Quantity 596 +0.3%
Value US$931
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 517,045 +8.8%
Value US$828,409
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 14,272 +8.6%
Value US$22,867
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 44,862 +0.8%
Value US$71,640
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 1,238 +0.8%
Value US$1,977
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.59
Quantity 64,420 +1.1%
Value US$102,196
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.59
Quantity 1,778 +1.1%
Value US$2,821
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 68,534 +1.2%
Value US$109,558
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 1,892 +1.2%
Value US$3,025
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.99
Quantity 970 +0.6%
Value US$1,928
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.99
Quantity 35,130 +0.6%
Value US$69,824
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.94
Quantity 124 +0.1%
Value US$240
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.94
Quantity 4,508 +0.1%
Value US$8,740
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.92
Quantity 3,094 +2.0%
Value US$5,938
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.82
Quantity 962 +0.6%
Value US$1,753
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.92
Quantity 112,106 +2.0%
Value US$215,165
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
1.82
Quantity 34,838 +0.6%
Value US$63,482
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.06
Quantity 98 +0.1%
Value US$202
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.08
Quantity 217 +0.1%
Value US$451
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.08
Quantity 609 +0.4%
Value US$1,267
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.08
Quantity 489 +0.3%
Value US$1,016
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.06
Quantity 3,550 +0.1%
Value US$7,313
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.08
Quantity 7,858 +0.1%
Value US$16,342
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.08
Quantity 22,055 +0.4%
Value US$45,894
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.08
Quantity 17,709 +0.3%
Value US$36,790
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.05
Quantity 1,222 +0.8%
Value US$2,509
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.06
Quantity 11 +0.0%
Value US$23
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.07
Quantity 1,393 +0.9%
Value US$2,885
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.05
Quantity 44,258 +0.8%
Value US$90,862
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.06
Quantity 389 +0.0%
Value US$801
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.07
Quantity 50,451 +0.9%
Value US$104,489
14159 capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.06
Quantity 159 +0.1%
Value US$328
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Purchase
Price
2.06
Quantity 5,755 +0.1%
Value US$11,855
BVF PARTNERS L P/IL Direct Beneficial Owner Large shareholder
Transaction date
Sale
Price
1.69
Quantity 166,000 -3.9%
Value US$280,972
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2011-12-13 2011-12-12 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
69,647 +18.1%
214.93
US$4,970,543 		69,647 +18.1% 214.93 US$4,970,543
2011-12-13 2011-12-09 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
64,704 -8.3%
280.46
US$2,284,185 		64,704 -8.3% 280.46 US$2,284,185
2011-12-13 2011-12-09 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
9,609 -29.8%
40.67
US$3,239,081 		9,609 -29.8% 40.67 US$3,239,081
2011-12-09 2011-12-08 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
1,180,983 +2.9%
4.25
US$5,019,178 		1,180,983 +2.9% 4.25 US$5,019,178
2011-12-09 2011-12-07 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
4,306,129 +11.9%
4.25
US$18,301,048 		4,306,129 +11.9% 4.25 US$18,301,048
2011-12-08 2011-12-06 B Purchase MADDEN DAVID Non-Executive Director
18,425 +1.7%
4.66
US$85,860 		18,425 +1.7% 4.66 US$85,860
2011-12-08 2011-12-06 B Purchase MADDEN DAVID Non-Executive Director
61,650 +6.0%
4.65
US$286,672 		61,650 +6.0% 4.65 US$286,672
2011-12-02 2011-12-02 B Purchase NICKELSON DONALD E Non-Executive Director
35,000 +11.4%
4.62
US$161,700 		35,000 +11.4% 4.62 US$161,700
2011-12-02 2011-12-02 B Purchase NICKELSON DONALD E Non-Executive Director
100,000 +48.1%
4.67
US$467,000 		100,000 +48.1% 4.67 US$467,000
2011-12-02 2011-12-02 B Purchase NICKELSON DONALD E Non-Executive Director
72,896 +53.9%
4.73
US$344,798 		72,896 +53.9% 4.73 US$344,798
2011-11-30 2011-11-22 B Purchase NICKELSON DONALD E Non-Executive Director
2,643 +2.0%
4.58
US$12,105 		2,643 +2.0% 4.58 US$12,105
2011-11-30 2011-11-21 B Purchase NICKELSON DONALD E Non-Executive Director
24,461 +22.6%
4.59
US$112,276 		24,461 +22.6% 4.59 US$112,276
2011-06-27 2011-06-27 B Purchase Webster Stephen W

SVP, Finance & CFO

Officer
10,000 +7.8%
1.88
US$18,800 		10,000 +7.8% 1.88 US$18,800
2011-06-22 2011-06-15 B Purchase Limongelli John M

SVP, General Counsel & Secr.

Officer
3,010 +1.6%
1.80
US$5,418 		3,010 +1.6% 1.80 US$5,418
2011-06-22 2011-06-14 B Purchase Limongelli John M

SVP, General Counsel & Secr.

Officer
13,190 +7.6%
1.90
US$25,061 		13,190 +7.6% 1.90 US$25,061
2010-12-23 2010-12-23 B Purchase DOUGHERTY MICHAEL R

President & CEO

Executive Director
30,000 +5.1%
1.18
US$35,400 		30,000 +5.1% 1.18 US$35,400
2010-10-29 2010-10-29 S Sale Baker Biotech Capital (GP), LLC Large shareholder
376 -0.5%
1.18
US$445 		376 -0.5% 1.18 US$445
2010-10-29 2010-10-29 S Sale Baker Bros. Capital (GP), LLC Large shareholder
14 -0.5%
1.18
US$17 		14 -0.5% 1.18 US$17
2010-10-29 2010-10-29 S Sale 14159 capital (GP), LLC Large shareholder
884 -0.5%
1.18
US$1,046 		884 -0.5% 1.18 US$1,046
2010-10-29 2010-10-29 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
60 -0.5%
1.18
US$71 		60 -0.5% 1.18 US$71
2010-10-29 2010-10-29 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
31,666 -0.5%
1.18
US$37,461 		31,666 -0.5% 1.18 US$37,461
2010-10-29 2010-10-28 S Sale Baker Biotech Capital (GP), LLC Large shareholder
885 -1.1%
1.19
US$1,052 		885 -1.1% 1.19 US$1,052
2010-10-29 2010-10-28 S Sale Baker Bros. Capital (GP), LLC Large shareholder
33 -1.1%
1.19
US$39 		33 -1.1% 1.19 US$39
2010-10-29 2010-10-28 S Sale 14159 capital (GP), LLC Large shareholder
2,086 -1.1%
1.19
US$2,479 		2,086 -1.1% 1.19 US$2,479
2010-10-29 2010-10-28 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
142 -1.1%
1.19
US$169 		142 -1.1% 1.19 US$169
2010-10-29 2010-10-28 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
74,670 -1.1%
1.19
US$88,738 		74,670 -1.1% 1.19 US$88,738
2010-10-29 2010-10-27 S Sale Baker Biotech Capital (GP), LLC Large shareholder
569 -0.7%
1.30
US$740 		569 -0.7% 1.30 US$740
2010-10-29 2010-10-27 S Sale Baker Bros. Capital (GP), LLC Large shareholder
21 -0.7%
1.30
US$27 		21 -0.7% 1.30 US$27
2010-10-29 2010-10-27 S Sale 14159 capital (GP), LLC Large shareholder
1,341 -0.7%
1.30
US$1,743 		1,341 -0.7% 1.30 US$1,743
2010-10-29 2010-10-27 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
91 -0.7%
1.30
US$118 		91 -0.7% 1.30 US$118
2010-10-29 2010-10-27 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
47,978 -0.7%
1.30
US$62,371 		47,978 -0.7% 1.30 US$62,371
2010-10-29 2010-10-27 S Sale Baker Biotech Capital (GP), LLC Large shareholder
233 -0.3%
1.28
US$298 		233 -0.3% 1.28 US$298
2010-10-29 2010-10-27 S Sale Baker Bros. Capital (GP), LLC Large shareholder
9 -0.3%
1.28
US$11 		9 -0.3% 1.28 US$11
2010-10-29 2010-10-27 S Sale 14159 capital (GP), LLC Large shareholder
550 -0.3%
1.28
US$702 		550 -0.3% 1.28 US$702
2010-10-29 2010-10-27 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
37 -0.3%
1.28
US$47 		37 -0.3% 1.28 US$47
2010-10-29 2010-10-27 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
19,671 -0.3%
1.28
US$25,120 		19,671 -0.3% 1.28 US$25,120
2010-06-02 2010-06-01 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
2,238 +0.0%
1.58
US$3,536 		2,238 +0.0% 1.58 US$3,536
2010-06-02 2010-06-01 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
405,401 +6.3%
1.64
US$664,736 		405,401 +6.3% 1.64 US$664,736
2010-06-02 2010-06-01 B Purchase 14159 capital (GP), LLC Large shareholder
62 +0.0%
1.58
US$98 		62 +0.0% 1.58 US$98
2010-06-02 2010-06-01 B Purchase 14159 capital (GP), LLC Large shareholder
11,190 +6.2%
1.64
US$18,348 		11,190 +6.2% 1.64 US$18,348
2010-06-02 2010-05-28 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
21,604 +0.3%
1.56
US$33,750 		21,604 +0.3% 1.56 US$33,750
2010-06-02 2010-05-28 B Purchase 14159 capital (GP), LLC Large shareholder
596 +0.3%
1.56
US$931 		596 +0.3% 1.56 US$931
2010-06-02 2010-05-28 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
517,045 +8.8%
1.60
US$828,409 		517,045 +8.8% 1.60 US$828,409
2010-06-02 2010-05-28 B Purchase 14159 capital (GP), LLC Large shareholder
14,272 +8.6%
1.60
US$22,867 		14,272 +8.6% 1.60 US$22,867
2010-05-27 2010-05-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
44,862 +0.8%
1.60
US$71,640 		44,862 +0.8% 1.60 US$71,640
2010-05-27 2010-05-27 B Purchase 14159 capital (GP), LLC Large shareholder
1,238 +0.8%
1.60
US$1,977 		1,238 +0.8% 1.60 US$1,977
2010-05-27 2010-05-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
64,420 +1.1%
1.59
US$102,196 		64,420 +1.1% 1.59 US$102,196
2010-05-27 2010-05-26 B Purchase 14159 capital (GP), LLC Large shareholder
1,778 +1.1%
1.59
US$2,821 		1,778 +1.1% 1.59 US$2,821
2010-05-27 2010-05-25 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
68,534 +1.2%
1.60
US$109,558 		68,534 +1.2% 1.60 US$109,558
2010-05-27 2010-05-25 B Purchase 14159 capital (GP), LLC Large shareholder
1,892 +1.2%
1.60
US$3,025 		1,892 +1.2% 1.60 US$3,025
2010-05-03 2010-04-30 B Purchase 14159 capital (GP), LLC Large shareholder
970 +0.6%
1.99
US$1,928 		970 +0.6% 1.99 US$1,928
2010-05-03 2010-04-30 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
35,130 +0.6%
1.99
US$69,824 		35,130 +0.6% 1.99 US$69,824
2010-05-03 2010-04-29 B Purchase 14159 capital (GP), LLC Large shareholder
124 +0.1%
1.94
US$240 		124 +0.1% 1.94 US$240
2010-05-03 2010-04-29 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
4,508 +0.1%
1.94
US$8,740 		4,508 +0.1% 1.94 US$8,740
2010-04-28 2010-04-28 B Purchase 14159 capital (GP), LLC Large shareholder
3,094 +2.0%
1.92
US$5,938 		3,094 +2.0% 1.92 US$5,938
2010-04-28 2010-04-28 B Purchase 14159 capital (GP), LLC Large shareholder
962 +0.6%
1.82
US$1,753 		962 +0.6% 1.82 US$1,753
2010-04-28 2010-04-28 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
112,106 +2.0%
1.92
US$215,165 		112,106 +2.0% 1.92 US$215,165
2010-04-28 2010-04-28 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
34,838 +0.6%
1.82
US$63,482 		34,838 +0.6% 1.82 US$63,482
2010-04-28 2010-04-27 B Purchase 14159 capital (GP), LLC Large shareholder
98 +0.1%
2.06
US$202 		98 +0.1% 2.06 US$202
2010-04-28 2010-04-27 B Purchase 14159 capital (GP), LLC Large shareholder
217 +0.1%
2.08
US$451 		217 +0.1% 2.08 US$451
2010-04-28 2010-04-27 B Purchase 14159 capital (GP), LLC Large shareholder
609 +0.4%
2.08
US$1,267 		609 +0.4% 2.08 US$1,267
2010-04-28 2010-04-27 B Purchase 14159 capital (GP), LLC Large shareholder
489 +0.3%
2.08
US$1,016 		489 +0.3% 2.08 US$1,016
2010-04-28 2010-04-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
3,550 +0.1%
2.06
US$7,313 		3,550 +0.1% 2.06 US$7,313
2010-04-28 2010-04-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
7,858 +0.1%
2.08
US$16,342 		7,858 +0.1% 2.08 US$16,342
2010-04-28 2010-04-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
22,055 +0.4%
2.08
US$45,894 		22,055 +0.4% 2.08 US$45,894
2010-04-28 2010-04-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
17,709 +0.3%
2.08
US$36,790 		17,709 +0.3% 2.08 US$36,790
2010-04-28 2010-04-26 B Purchase 14159 capital (GP), LLC Large shareholder
1,222 +0.8%
2.05
US$2,509 		1,222 +0.8% 2.05 US$2,509
2010-04-28 2010-04-26 B Purchase 14159 capital (GP), LLC Large shareholder
11 +0.0%
2.06
US$23 		11 +0.0% 2.06 US$23
2010-04-28 2010-04-26 B Purchase 14159 capital (GP), LLC Large shareholder
1,393 +0.9%
2.07
US$2,885 		1,393 +0.9% 2.07 US$2,885
2010-04-28 2010-04-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
44,258 +0.8%
2.05
US$90,862 		44,258 +0.8% 2.05 US$90,862
2010-04-28 2010-04-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
389 +0.0%
2.06
US$801 		389 +0.0% 2.06 US$801
2010-04-28 2010-04-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
50,451 +0.9%
2.07
US$104,489 		50,451 +0.9% 2.07 US$104,489
2010-04-28 2010-04-26 B Purchase 14159 capital (GP), LLC Large shareholder
159 +0.1%
2.06
US$328 		159 +0.1% 2.06 US$328
2010-04-28 2010-04-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
5,755 +0.1%
2.06
US$11,855 		5,755 +0.1% 2.06 US$11,855
2009-09-24 2009-09-22 S Sale BVF PARTNERS L P/IL

Direct Beneficial Owner

Large shareholder
166,000 -3.9%
1.69
US$280,972 		166,000 -3.9% 1.69 US$280,972
Explore more

More insider trading research around Adolor Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America